Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole hydrogel 25% in Stage II and III Periodontitis
NCT04983849Phase 4Completed
- Sponsor
- Università degli Studi dell'Aquila
- Start
- Jul 2021
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of metronidazole in periodontitis, sponsored by Università degli Studi dell'Aquila. Primary endpoints: Matrix Metalloproteinase 8 at 1 week and Matrix Metalloproteinase 9 at 1 week. Started Jul 2021; status: completed.
02
Drugs
metronidazole
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT04983849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04983849.